v3.25.1
Stockholders’ Equity (Details) - USD ($)
 3 Months Ended
May 09, 2024
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Stockholders’ Equity [Line Items]        
Common stock available for sale (in Dollars) $ 150,000,000      
Gross proceeds percentage   3.00%    
Net proceeds (in Dollars)   $ 6,761,573  
Capacity remaining program (in Dollars)   $ 100,000,000    
Preferred stock, shares authorized   2,000,000   2,000,000
Preferred stock, par value (in Dollars per share)   $ 0.001   $ 0.001
Shares of common stock issued   67,711,098   64,411,295
Period of unrecognized compensation expense   1 year 3 months 18 days    
Net proceeds of exercised stock options (in Dollars)   $ 350,350  
Weighted average exercise price (in Dollars per share)   $ 4.17    
Aggregate intrinsic value (in Dollars)   $ 530,000    
Expected dividend yield, percentage   0.00%    
Stock Options [Member]        
Stockholders’ Equity [Line Items]        
Net proceeds of exercised stock options (in Dollars)   $ 350,000    
Board of Directors [Member]        
Stockholders’ Equity [Line Items]        
Preferred stock, shares authorized   2,000,000    
Common Stock [Member]        
Stockholders’ Equity [Line Items]        
Issuance of exercised stock options   84,091    
Shares of common stock issued     1,911,167  
2024 ATM Program [Member] | Common Stock [Member]        
Stockholders’ Equity [Line Items]        
Common stock available for sale (in Dollars)   $ 23,200,000    
Net proceeds (in Dollars)   $ 6,800,000    
Stock Options [Member]        
Stockholders’ Equity [Line Items]        
Number of vesting shares   1,274,750    
Number of grant date shares (in Dollars per share)   $ 10.21    
Shares of common stock issued   487,500    
Outstanding RSUs and PSU   1,861,036 366,235  
Unrecognized compensation expense (in Dollars)   $ 16,871,000    
Period of unrecognized compensation expense   2 years    
Stock Options [Member] | Executive Officers [Member]        
Stockholders’ Equity [Line Items]        
Vested shares issued (in Dollars per share)   $ 11.79    
Employee Stock Option [Member]        
Stockholders’ Equity [Line Items]        
Unrecognized compensation expense (in Dollars)   $ 5,176,000    
Leerink Partners LLC [Member]        
Stockholders’ Equity [Line Items]        
Sale of common stock (in Dollars) $ 50,000,000      
Executive Officers [Member] | Stock Options [Member]        
Stockholders’ Equity [Line Items]        
Granted shares issued     283,333  
Weighted average grant date fair value (in Dollars per share)     $ 3.47  
Series G Preferred Stock [Member]        
Stockholders’ Equity [Line Items]        
Issuance of exercised stock options   45,000    
Issuance shares of common stock   2,502,062    
2024 ATM Program [Member]        
Stockholders’ Equity [Line Items]        
Sold an aggregate of shares   620,444